Auris Health is a California-based company with a stated mission of creating a world where patient care is not pre-determined by medical tools that are limiting. It creates new tools for less invasive procedures for patients.
The Monarch Platform is the first robotics platform cleared by the Federal Drug Administration and is designed for diagnostic and therapeutic bronchoscopic procedures. The platform is designed to be used by physicians to access small and hard-to-reach lung nodules for early diagnoses and targeted treatment of lung cancer. The endoscope itself is designed for greater reach and control and can be used via a controller interface, which the physician uses to navigate the periphery of the lungs. The platform can give 3D visuals of the patient's lungs so that physicians can have more access to the entirety of the organ.
The Monarch Platform has received several awards, including the Red Dot Award for best of the best product design, where the product was tested in various categories such a longevity and functionality.
Johnson & Johnson announces that its Ethicon completed its $3.4 billion acquisition of Auris Health and the $2.8 billion divestiture of its Advanced Sterilization Products to Fortive.
Johnson & Johnson announced it was buying Auris Health
J&J said it would pay $3.4b in a cash deal and $2.35b more if Auris met predetermined milestones.
Auris Health raises a $280,000,000 series D round from Coatue Management, Highland Capital Partners, Lux Capital Management and Mithril Capital Management.
Auris Health was founded.
VICE PRESIDENT OF OPERATIONS
DAVID M. STYKA
CHIEF FINANCIAL OFFICER
FRED MOLL, M.D.
FOUNDER AND CHIEF EXECUTIVE OFFICER
CHIEF STRATEGY OFFICER
Documentaries, videos and podcasts
- Cluster: RoboticsA cluster of topics related to robotics.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- Unicorn (finance)A privately held startup company with an evaluation above $1 billion.